Immunoglobulin Support for Patients with Hematologic Malignancies: When Should You Discuss Starting, How Should You Dose, and When Is It Safe to Consider Stopping – lesson

Home > Immunoglobulin Support for Patients with Hematologic Malignancies: When Should You Discuss Starting, How Should You Dose, and When Is It Safe to Consider Stopping – lesson

07 Nov Immunoglobulin Support for Patients with Hematologic Malignancies: When Should You Discuss Starting, How Should You Dose, and When Is It Safe to Consider Stopping – lesson

Posted at 13:32h in Video by
Immunoglobulin Support for Patients with Hematologic Malignancies: When Should You Discuss Starting, How Should You Dose, and When Is It Safe to Consider Stopping – Webinar Immunoglobulin Support for Patients with Hematologic Malignancies: When Should You Discuss Starting, How Should You Dose, and When Is It Safe to Consider Stopping – lesson
Back to Case Study
Tags: